FAM186B Inhibitors
Chemical inhibitors of FAM186B can disrupt the protein's function by targeting various signaling pathways and kinases. Staurosporine is one such inhibitor, known for its broad-spectrum inhibition of protein kinases. It can halt the activation of signaling pathways that are essential for FAM186B's role within the cell. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinase (PI3K) inhibitors, can impede the PI3K pathway, leading to the inhibition of downstream proteins including FAM186B. This disruption is significant as PI3K is a pivotal point of convergence for multiple signaling cues. U0126 and PD98059, which selectively inhibit MEK1/2 within the MAPK/ERK pathway, can prevent the activation of downstream elements that may be necessary for FAM186B's function. By blocking MEK, the subsequent phosphorylation and activation of proteins in this pathway are interrupted.
In addition to the MAPK/ERK pathway inhibitors, SB203580 and SP600125 target other MAP kinase pathways. SB203580 specifically inhibits p38 MAP kinase, while SP600125 is an inhibitor of the c-Jun N-terminal kinase (JNK) pathway. The inhibition of these kinases can lead to a decrease in FAM186B activity due to the disruption of signaling processes that regulate its activity. Rapamycin's inhibition of mTOR, a central regulator of cell growth, can also affect FAM186B by disrupting mTOR-related signaling cascades. Furthermore, PP2 targets Src family tyrosine kinases which when inhibited, can affect the phosphorylation state and function of numerous proteins including FAM186B. Lastly, Bisindolylmaleimide I and Gö 6983 are inhibitors of protein kinase C (PKC), and K252a is a kinase inhibitor that targets PKC, PKA, and PKG. By impeding these kinases, these inhibitors can lead to a reduction in FAM186B activity, as PKC, PKA, and PKG are crucial for the phosphorylation and subsequent activation of many cellular proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, known to disrupt various signaling pathways. As FAM186B is a protein that may interact with kinase-regulated pathways, staurosporine can inhibit these pathways, leading to the functional inhibition of FAM186B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a selective inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in many signaling pathways, including those regulating proteins like FAM186B. Inhibition of PI3K can disrupt the signaling necessary for FAM186B function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are part of the MAPK/ERK pathway. Since FAM186B may function downstream of this pathway, U0126 can lead to its functional inhibition by preventing MEK activation and subsequent signaling events. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, which is involved in the MAPK pathway, SB203580 can functionally inhibit FAM186B by disrupting signaling processes that regulate its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator in cell growth and proliferation. As FAM186B could be regulated by signaling pathways involving mTOR, its functional inhibition can result from the disruption of mTOR activity by rapamycin. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which through the inhibition of PI3K, can obstruct the activation of downstream proteins, including FAM186B, leading to its functional inhibition by halting the PI3K-dependent signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of the ERK pathway. By blocking MEK, PD98059 can prevent the downstream signaling necessary for FAM186B function, resulting in its inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK by SP600125 can result in the functional inhibition of FAM186B by preventing the phosphorylation and activation of proteins that are regulated by JNK. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases, which are involved in various signaling cascades. By inhibiting Src kinases, PP2 can functionally inhibit FAM186B if it is regulated by these kinases. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC). If FAM186B is regulated by PKC, its functional inhibition can be achieved by preventing PKC-mediated signaling processes with this inhibitor. | ||||||